Episode #24: JPMorgan Insider Tells All: The Hidden Damage Big Banks Do to Investors

 

How much damage can big banks do to investors? To hear it from a JPMorgan insider, it’s the hidden stuff that hurts the most.

In the latest episode of Untamed Ethos, hosted by Dr. Joshua Wilson, listeners and viewers are privy to an unflinchingly candid discussion with Robert M. Mennella, the author of “Heavily Redacted: A JPMorgan Whistleblower’s Journey.” Mennella, with the expertise of a seasoned Wall Street veteran and Founder of EQW/ Eqwitty Research, pulls back the corporate curtain to shine a light on the darker practices within JPMorgan Chase, a financial behemoth whose influence spans the globe.

Mennella details with chilling clarity the myriad ways the bank’s advisors, bound by a system that incentivizes personal and corporate gain over client welfare, are steered into pushing bank-profitable products. He expounds on how opaque fees, misrepresented investment performances, and unsuitable product recommendations have become commonplace, potentially compromising the financial health of unsuspecting clients. Mennella doesn’t shy away from calling out the regulatory evasion techniques employed by the bank or discussing the unsettling impact of a mysterious $500,000 from JPMorgan that coincided with investigatory proceedings.

This episode promises a rare window into the mechanisms by which some big banks may place profits before their clients, underscoring the need for a transformative shift toward transparency and ethicality in the financial industry. The dialogue is also a call to action, empowering investors with the knowledge required to navigate the complexity of investment with big banks.

Untamed Ethos invites its audience to engage in this conversation by sharing their experiences and subscribing to the channel for more enlightening content. Mennella’s book is also available for those looking to delve deeper into his journey and the revelations he brings to the fore.

Amidst a world where financial maneuverings often remain obscured from the public eye, Untamed Ethos stands as a beacon of truth, advocating for the informed investor and an industry that upholds integrity at its core.

Read Mennella’s groundbreaking work, “Heavily Redacted: A JPMorgan Whistleblower’s Journey,” available at Amazon.

For more content and to share your experience, subscribe on YouTube at

www.youtube.com/@Dr_JoshuaWilson

Remember, awareness is the first step towards meaningful change. Join this pivotal discussion and contribute to paving the way for a financial industry that prizes ethical practice as its guiding principle.

Follow us on social media for the latest updates in B2B!

Image

Latest

Doable
Rethinking Leadership: Why “Doable” Might Be the Most Powerful Strategy in Education Today
April 3, 2026

At a time when educator burnout is rising and schools across the U.S. are facing ongoing teacher shortages, leaders are being forced to rethink what sustainable success actually looks like. Research shows that teacher attrition is closely tied to working conditions, job-related stress, and workload demands. As districts push for innovation, data-driven instruction, and…

Read More
Casey Brown
From Poverty to Pricing Power | Why Great Companies Undercharge
April 2, 2026

Casey Brown didn’t grow up thinking she would become an entrepreneur. She grew up in a blue-collar family where money was always tight — close enough to the edge that the fear of poverty shaped many of her early decisions. That fear led her into engineering, into corporate America, and eventually into a moment…

Read More
Nightingales Summit: Empowering the Next Generation of Nigerian Nurses
Nightingales Summit: Empowering the Next Generation of Nigerian Nurses
April 2, 2026

In this episode of Care Anywhere, host Lea Sims sits down with Nigerian nurse entrepreneur and advocate Obafemi Arowosegbe to discuss leadership, mentorship, and the future of nursing in Africa. While still a nursing student, Obafemi founded the Nightingale Summit, a growing conference designed to empower nursing students and early-career nurses with leadership skills,…

Read More
Oncology
From Denial to Access: Rethinking Oncology Care Through AI, Clinical Trials, and Patient-Centered Innovation
April 1, 2026

The rapid expansion of precision medicine, biologics, and targeted cancer therapies is transforming oncology—but it’s also overwhelming a system not built to keep pace. In the U.S., cancer drugs now account for some of the highest-cost treatments in healthcare, and with that has come a surge in prior authorization requirements and denials. Studies suggest physicians…

Read More